- About Us
- Our Research
- Diseases and conditions
- Research Groups
- Research support and facilities
- Aboriginal and Torres Strait Islander Health
- Participate in our research
- Research highlights
- Research history
- Glossary of research terms
- Support Us
- Why support QIMR Berghofer?
- Ways to help
- Book a tour or guest speaker
- Our supporters
- Thanks to our donors
- News & Events
- Media releases
- Lifelab newsletter
- Media centre
- Annual Report
- Contact Us
- Our Services
- CMV study
- Queensland Pancreatic Cancer Study
- QIMR Berghofer Centre for Immunotherapy and Vaccine Development
|Share on Facebook||Share on Twitter||Share on LinkedIn|
QIMR Berghofer Medical Research Institute is:
We have an active program for the patenting and commercialisation of technologies, including those developed in conjunction with academic or commercial collaborators.
QIMR Berghofer also has facilities for the GMP manufacture of cell-based and molecular therapies. Co-located within the Institute is a commercial Phase I/II clinical trials facility, Q-Pharm Pty Ltd allowing QIMR Berghofer scientists and external clients the extended and unique capability for taking research findings from bench to the bedside.
More about QIMR Berghofer
is home to over 700 scientists, students and support staff
Established in 1945 by the Queensland Government, the QIMR Berghofer Medical Research Institute (formerly the Queensland Institute of Medical Research) is a world leading translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases.
Working in close collaboration with clinicians and other research institutes, our aim is to improve health by developing new diagnostics, better treatments and prevention strategies.
QIMR Berghofer is home to more than 700 scientists, students and support staff in six research departments (in over 50 separate laboratories) and a support division.
ABN: 31 411 813 344